Clinical Research Directory
Browse clinical research sites, groups, and studies.
Xeomin® and Gait Related Mobility After Stroke
Sponsor: Wake Forest University Health Sciences
Summary
The aim of the present pilot study is to evaluate the association between change in gait related mobility in ambulatory male and female adult hemiparetic patients before and 4-6-weeks after Xeomin® injection into the upper limb, using two standardized tests of physical function in outpatient rehabilitation that are widely used; the 10-meter walk test and the timed 'up and go' test (TUG).
Official title: Upper Extremity Injection of Xeomin® and Changes in Gait Related Mobility in Adults After Stroke
Key Details
Gender
All
Age Range
18 Years - 79 Years
Study Type
INTERVENTIONAL
Enrollment
20
Start Date
2021-10-19
Completion Date
2027-04
Last Updated
2025-11-25
Healthy Volunteers
No
Conditions
Interventions
Xeomin®
To discover whether injection into the upper extremity with Xeomin® triggers improvements in gait-related mobility and quality of life in adults with hemiparesis secondary to stroke.
Locations (1)
Carolinas Rehabilitation
Charlotte, North Carolina, United States